Nonpharmacologic treatment of atrial fibrillation: Current and evolving strategies

Chest

Volumn 112, Issue 4, 1997, Pages 1079-1090

  Iskos, Demosthenes ^a   Fahy, Gerard J ^a   Lurie, Keith G ^a   Sakaguchi, Scott ^a   Adkisson, Wayne O ^a   Benditt, David G ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

Atrial defibrillation; Atrial fibrillation; Cardioversion; Pacemakers; Radiofrequency energy ablation

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CATHETER ABLATION; DEFIBRILLATION; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW; WOLFF PARKINSON WHITE SYNDROME;

EID: 0030821153     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.4.1079     Document Type: Review

References (105)

1. Ostrander LD Jr, Brandt RL, Kjelsberg MO, et al. Electrocardiographic findings among the adult population of a total natural community: Tecumseh, Michigan. Circulation 1965; 31:888-98
2. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982; 306:1018-22
3. Lake FR, Cullen KJ, de Klerk NH, et al. Atrial fibrillation and mortality in an elderly population. Aust N Z J Med 1989; 19:321-26
4. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation 1991; 84:527-39
5. Peters KG, Kienzle MG. Severe cardiomyopathy due to chronic rapidly conducting atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Med 1988; 85:242-44
6. Coplen SE, Antman EM, Berlin JA, et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized controlled trials. Circulation 1990; 82:1106-16
7. Crijns HJ, Van Gelder IC, Van Gilst WH, et al. Serial antiarrhythmic drug treatment to maintain sinus rhythm alter electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol 1991; 68:335-41
8. Hohnloser SH, Wossley RL, Sotalol. N Engl J Med 1994; 331:31-38
9. Mason JW. Amiodarone. N Engl J Med 1987; 316:455-66
10. Chun SH, Sager PT, Stevenson WG, et al. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 1995; 76:47-50
11. Gallagher JJ, Svenson RH, Kasell JH, et al. Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 1982; 306:194-200
12. Scheinman MM, Morady F, Hess DS, et al. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA 1982; 248: 851-55
13. Evans GT, Scheinman MM, Zipes DP, et al. The Percutaneous Cardiac Mapping and Ablation Registry: summary of results. PACE 1987; 10:1395-1400
14. Evans GT, Scheinman MM, Bardy G, et al. Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction: results of a prospective, international, multicenter study. Circulation 1991; 84:1924-37
15. Huang SK, Bharati S, Graham AR, et al. Closed-chest catheter desiccation of the atrioventricular junction using radiofrequency energy - a new method of catheter ablation. J Am Coll Cardiol 1987; 9:349-58
16. Langberg JJ, Chin M, Schamp DJ, et al. Ablation of the atrioventricular junction with radiofreqnency energy using a new electrode catheter. Am J Cardiol 1991; 67:142-47
17. Sousa J, El-Atassi R, Rosenheck S, et al. Radiofrequency catheter ablation of the atrioventricular junction from the left ventricle. Circulation 1991; 84:567-71
18. Morally F, Calkins H, Langberg JJ, et al. A prospective randomized comparison of direct current and radiofrequency ablation of the atrioventricular junction. J Am Coll Cardiol 1993; 21:102-09
19. Brignole M, Menozzi C. Control of rapid heart rate in patients with atrial fibrillation: drugs or ablation? PACE 1996; 19:348-56
20. Olgin JE, Scheinman MM. Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction. J Am Coll Cardiol 1993; 21:557-64
21. Huang SKS, Wagshal A, Mittleman RS, et al. Sudden cardiac death after complete radiofreqnency catheter ablation of the atrioventricular junction - a multicenter prospective study [abstract]. Circulation 1994; 90(suppl):I-335
22. De Lima G, Talajic M, Dubuc M, et al. Malignant ventricular arrhythmias after atrioventricular nodal ablation: a long term follow-up study [abstract]. Circulation 1996; 94(suppl): I-682
23. Jensen SM, Bergfelt L, Rosenqvist M. Long-term follow-up of patients treated by radiofrequency ablation of the atrioventricular junction. PACE 1995; 18:1609-14
24. Twidale N, Sutton K, Bartlett L, et al. Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug refractory atrial arrhythmias. PACE 1993; 16:1275-84
25. Brignole M, Gianfranchi L, Menozzi C, et al. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 1994; 74:242-46
26. Rodriguez LM, Smeets J, Xie B, et al. Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with atrial fibrillation. Am J Cardiol 1993; 72:1137-41
27. Kay GN, Ellenbogen KA, Guidici M, et al. Survival in the APT Trial: a prospective registry of AV nodal ablation and permanent pacemaker implantation for symptomatic atrial fibrillation [abstract]. Circulation 1996; 94:I-682
28. Kay GN, Bubien RS, Dailey SM, et al. A prospective evaluation of intracoronary ethanol ablation of the atrioventricular conduction system. J Am Coll Cardiol 1991; 17: 1634-40
29. Brugada P, de Swart H, Smeets J, et al. Transcoronary chemical ablation of atrioventricular conduction. Circulation 1990; 81:757-61
30. Williamson BD, Man KC, Daoud E, et al. Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation. N Engl J Med 1994; 331:910-17
31. Feld G, Fleck P, Fujimura O, et al. Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. Circulation 1994; 90:2299-2307
32. Della Bella P, Carbucicchio C, Tondo C, et al. Modulation of atrioventricular conduction by ablation of the 'slow' atrioventricular node pathway in patients with drug-refractort atrial fibrillation or flutter. J Am Coll Cardiol 1995; 25:39-46
33. Striekberger SA, Weiss R, Daoud EG, et al. Ventricular rate during atrial fibrillation before and after slow-pathway ablation: effects of autonomic blockade and β-adrenergic stimulation. Circulation 1996; 94:1023-26
34. Kreiner C, Heinz G, Siostrzonek P, et al. Effect of slow pathway ablation on ventricular rate during atrial fibrillation, dependence on electrophysiological properties of the fast pathway. Circulation 1996; 93:277-83
35. Wellens HJ. Atrial fibrillation - the last big hurdle in treating supraventricular tachycardia. N Engl J Med 1994; 331:943-45
36. Hesselson AB, Parsonnet V, Bernstein AD, et al. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus svndrome: the hidden benefits of dual-chamber pacing. J Am Coll Cardiol 1992; 19:1542-49
37. Rosenijvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988; 116: 16-22
38. Santini M, Alexidon G, Ansalone G, et al. Relation of prognosis in sick sinus syndrome to age, conduction defect and modes of permanent cardiac pacing. Am J Cardiol 1990; 65:729-35
39. Stangl K, Seitz K, Wirtzfeld A, et al. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effects in patients with sick sinus syndrome. PACE 1990; 13:2080-85
40. Andersen HR, Thuesen L, Bagger JP, et al. Prospective randomized trial of atrial versus ventricular pacing in sicksinus syndrome. Lancet 1994; 344:1523-28
41. Lamas CA, Estes NM III, Schneller S, et al. Does dualchamber or atrial pacing prevent atrial fibrillation? The need for a randomized controlled trial. PACE 1992; 15:1109-13
42. Hayes DL, Neubauer SA. Incidence of atrial fibrillation after DDD pacing [abstract]. PACE 1990; 13:501
43. Adornato E, Monca P, Pennisi Y, et al. Comparative evaluation ol DDDB and DDD pacing modes in the prevention of atrial fibrillation [abstract]. PACE 1993; 16:1145
44. Coumel P, Attnel P, Lavallee JP, et al. Syndrome d'arythmie auriculaire d'origine vagale. Arch Mal Cocur 1978; 71: 645-56
45. Coumel P, Friocourt P, Mugica J, et al. Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: experience with 6 cases. PACE 1983; 6:552-60
46. Daubert C, Mabo P, Berder V, et al. Atrial tachyarrhythmias associated with high degree interatrial conduction block: prevention by permanent atrial resynchronization. Eur J P E 1994; 4:35-44
47. Danbert C, Mabo P, Berder V, et al. Permanent dual atrium pacing in major interatrial conduction block: a four years experience [abstract]. PACE 1993; 16:885
48. Prakash A, Hill M, Lewis C, et al. Comparative efficacy of high right atrial, coronary sinus and dual site right atrial pacing in prevention of atrial fibrillation [abstract]. PACE 1996; 19:634
49. Sopher SM, Murgatroyd FD. Slade AKB, et al. Dual site atrial pacing promotes sinus rhythm in paroxysmal atrial fibrillation [abstract]. Circulation 1995; 92:1-532
50. Prakash A, Saksena S, Hill M, et al, Long-term results with dual and single site atrial pacing for prevention of atrial fibrillation [abstract]. Circulation 1996; 94:I-68
51. Murgatroyd FD, Nitzsche R, Slade AKB, et al. A new pacing algorithm for overdrive suppression of atrial fibrillation. PACE 1994: 17(pt II):1966
52. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962; 140:183-88
53. Allessie MA, Bonke FIM, Schopman FJG. Circus movement and rapid atrial muscle as a mechanism of tachycardia: III. the 'leading circle' concept: a new model of circus movement in cardiac tissue without the involvement of an anatomic obstacle. Circ Res 1977; 41:9-18
54. Konings KTS, Kirchhof CJHJ, Smeets JRLM, et al. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994; 89:1665-80
55. Cox JL, Canavan TE, Schnessler RB, et al. The surgical treatment of atrial fibrillation: II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991; 101:406-26
56. Leitch JW, Klein G, Yee R, et al. Sinus node-atrioventricular node isolation: long-term results with the 'corridor' operation for atrial fibrillation. J Am Coll Cardiol 1991; 17:970-75
57. Van Hemel NM, Defaw JJAMT, Kingma JH, et al. Long-term results of the corridor operation for atrial fibrillation. Br Heart J 1994; 71:170-76
58. Cox JL, Schuessler RB, D'Agostino HJ Jr, et al. The surgical treatment of atrial fibrillation: III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991; 101:569-83
59. Cox JL, Boineau JP, Schuessler RB, et al. Five-year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg 1993; 56:814-24
60. Feinberg MS, Waggoner AD, Kater KM, et al. Echocardiographic automatic boundary detection to measure left atrial function alter the maze procedure. J Am Soc Echochardiogr 1995; 8:139-48
61. Sandoval N, Velasco VM, Orjnela H, et al. Concomitant mitral valve or atrial septal defect surgery and the modified Cox-maze procedure. Am J Cardiol 1996; 77:591-96
62. Kosakai Y, Kawaguchi AT, Isobe F, et al. Modified maze procedure for patients with atrial fibrillation undergoing simultaneous open heart surgery. Circulation 1995; 92(suppl II):II-359-64
63. Elvan A, Pride HP, Eble JN, et al. Radiofreqnency catheter ablation of the atria reduces inducibility and duration of atrial fibrillation in dogs. Circulation 1995; 91:2235-44
64. Swartz JF, Pellersels G, Silvers J, et al. A catheter-based curative approach to atrial fibrillation in humans [abstract]. Circulation 1994; 90(suppl):I-335
65. Jais P, Haissaguerre M, Shah DC, et al. Catheter ablation for paroxysmal atrial fibrillation: high success rates with ablation in the left atrium [abstract]. Circulation 1996; 94(snppl):I-675-76
66. Katritsis D, Fragakis N, Iliodromitis EK, et al. Catheter ablation for radical cure of atrial fibrillation [abstract]. Circulation 1996; 94(suppl):I-682
67. Haissaguerre M, Gencel L, Fischer B, et al. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1994; 5:1045-52
68. Natale A, Tomassoni G, Kearney MA, et al. Catheter ablation approach on the right side only for paroxysmal atrial fibrillation therapy [abstract]. Circulation 1995; 92(suppl):I-266
69. Olgin JE, Kalman JM, Maguire M, et al. Electrophysiologic effects of long linear atrial lesions placed under intracardiac echo guidance [abstract]. PACE 1996; 19:581
70. Haissaguerre M, Marcus FI, Fischer B, et al. Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: report of three cases. J Cardiovusc Electrophysiol 1994; 5:743-51
71. Katritsis D, Iliodromitis E, Fragakis N, et al. Ablation therapy of type I flutter may eradicate paroxysmal atrial fibrillation. Am J Cardiol 1996; 78:345-47
72. Campbell RW, Smith RA, Gallagher JJ, et al. Atrial fibrillation in the pre-excitation syndrome. Am J Cardiol 1977; 40:514-20
73. Welleus HJ, Durrer D, Wolff-Parkinson-White syndrome and atrial fibrillation. Am J Cardiol 1974; 34:777-82
74. Wathen M, Natale A, Wolfe K, et al. Initiation of atrial fibrillation in the Wolff-Parkinson-White syndrome: the importance of the accessory pathway. Am Heart J 1993; 125:753-59
75. Kalbfleisch SJ, El-Atassi R, Calkins H, et al. Inducibility of atrial fibrillation before and after radiofrequency catheter ablation of accessory atrioventricnlar connections. J Cardiovasc Electrophysiol 1993; 4:499-503
76. Sharma AD, Klein GJ, Guirandon GM, et al. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway Circulation 1985; 72:161-69
77. Haissaguerre M, Fischer B, Labbe T, et al. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways. Am J Cardiol 1992; 69:493-97
78. Guidelines for cardiopulmonary resuscitation and emergent cardiac care: recommendations of the 1992 National Conference. JAMA 1992; 268:2211-13
79. Kerber RE. External direct current cardioversion-defibrillation. In: Zipes D, Jalife J, eds. Cardiac electrophysiology from cell to bedside. Philadelphia: WB Saunders, 1990; 1360-65
80. DeSilva RA, Graboys TB, Podrid PJ, et al. Cardioversion and defibrillation. Am Heart J 1980; 100:881-95
81. Kerber RE, Grayzel J, Hoyt R, et al. Transthoracic resistance in human defibrillation: influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation 1981; 63:676-82
82. Paulk EA Jr, Hurst JW. Clinical problems of cardioversion. Am Heart J 1965; 70:248-74
83. Sutton RB, Tsagaris TJ. Pulmonary edema following direct current cardioversion. Chest 1970; 57:191-94
84. Levy S, Lacombe P, Cointe R, et al. High energy transcatheter cardioversion of chronic atrial fibrillation. J Am Coll Cardiol 1988; 12:514-18
85. Levy S, Lauribe P, Dolla E, et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992; 86:1415-20
86. Lerman BB, Deale OC. Relation between transcardiac and transthoracic current during defibrillation in humans. Circ Res 1990; 67:1420-26
87. Dunbar DN, Tobler HG, Fetter J, et al. Intracavitary electrode catheter cardioversion of atrial tachyarrhythmias in the dog. J Am Coll Cardiol 1986; 7:1015-27
88. Kalman JM, Power JM, Chen JM, et al. Importance of electrode design, lead configuration and impedance for successful low energy transcatheter atrial fibrillation in dogs. J Am Coll Cardiol 1993; 22:1199-1206
89. Cooper RAS, Alferness CA, Smith WM, et al. Internal cardioversion of atrial fibrillation in sheep. Circulation 1993; 87:1673-86
90. Alt E, Scmitt C, Ammer R, et al. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE 1994; 17:1067-78
91. Johnson EE, Yarger MD, Wharton JM. Monophasic and biphasic waveforms for low energy internal cardioversion of atrial fibrillation in humans [abstract]. Circulation 1993; 88:3184
92. Murgatroyd FD, Slade AKB, Sopher SM, et al. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1995; 25:1347-53
93. Cooper RAS, Johnson EE, Wharton JM. The improved efficacy of asymmetric hiphasic waveforms for internal cardioversion of atrial fibrillation in humans [abstract]. PACE 1995; 18:896
94. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995; 92:1954-68
95. Levy S, Camm J. An implantable atrial fibrillator: an impossible dream? [editorial]. Circulation 1993; 87:1769-72
96. Saksena S, Prakash A, Mangeon L, et al. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardiol 1995; 76:913-21
97. Iskos D, Lurie KG, Adler SW, et al. Effect of parenteral d-sotalol on transvenous atrial defibrillation threshold in a canine model of atrial fibrillation. Am Heart J 1996; 132: 116-19
98. Harbinson M, Tronton T, Imam Z, et al. Transvenous catheter atrial defibrillation using rounded versus standard biphasic waveforms [abstract]. PACE 1996; 19(pt II):696
99. Pinski SL, Fahy GJ. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995; 92: 1651-64
100. Avers GM, Alferness CA, Ilina M, et al. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation 1994; 89:413-22
101. Ruffy R. The automatic implantable defibrillator: it can be done, hut should it? [editorial]. J Cardiovasc Electrophysiol 1995; 6:649-51
102. Lau CP, Tse HF, Jung W, et al. Safety and efficacy of a human implantahle defibrillator for atrial fibrillation [abstract]. Circulation 1996; 94:I-562
103. Huang-Fat T, Chu-Pak L, Adler S, et al. The efficacy for atrial defibrillation detection and R-wave synchronization for shock delivery in patients with implantable human atrial defibrillator [abstract]. Circulation 1996; 94:I-67
104. Collins SM, Arzbaecher RC. Feedback control in the management of cardiac arrhythmias. Biomed Sci Instrumentation 1978; 14:157-62
105. Lurie KG, Buscemi P, Iskos D, et al. Comparison of right atrial and peripheral procainamide levels for the treatment of atrial fibrillation [abstract]. PACE 1997; 20:1143